GOLDMAN SACHS GROUP INC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Back to ARWR Full portfolio

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$93,737,069

-$15,356,102 QoQ

Shares Held

1,150,007

-33.9% QoQ

Ownership

0.814%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#20

of 497 holders

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Derivatives in ARWR

reported options exposure · as of Sep 30, 2025

CallValue

$1,714,153

CallShares

49,700

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. ARWR ranks #38 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

All Filings in ARWR

Export CSV

34 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$93,737,069	1,150,007	-33.9%	Shares	Defined	2026-08-14
2026-03-31	$109,093,171	1,739,923	-1.9%	Shares	Defined	2026-05-15
2025-09-30	$1,714,153	49,700	-38.9%	Call	Defined	2025-11-14
2025-09-30	$61,181,051	1,773,878	-16.1%	Shares	Defined	2025-11-14
2025-06-30	$1,284,540	81,300	+713.0%	Call	Defined	2025-08-14
2025-06-30	$33,421,960	2,115,314	+21.5%	Shares	Defined	2025-08-14
2025-03-31	$22,188,824	1,741,666	+34.6%	Shares	Defined	2025-06-27
2024-12-31	$24,331,147	1,294,210	+1.7%	Shares	Defined	2025-02-11
2024-09-30	$24,656,091	1,272,901	+0.7%	Shares	Defined	2024-11-14
2024-06-30	$32,836,857	1,263,442	+20.4%	Shares	Defined	2024-08-13
2024-03-31	$30,016,815	1,049,539	-1.2%	Shares	Defined	2024-05-15
2023-12-31	$32,496,190	1,061,967	+136.6%	Shares	Defined	2024-05-14
2023-09-30	$12,061,942	448,900	-30.0%	Shares	Defined	2024-05-15
2023-06-30	$22,861,125	641,086	-10.0%	Shares	Defined	2024-05-14
2023-03-31	$18,099,810	712,591	-4.8%	Shares	Defined	2024-05-14
2022-12-31	$30,365,365	748,653	-26.8%	Shares	Defined	2024-05-14
2022-09-30	$33,820,758	1,023,321	+4.8%	Shares	Defined	2024-05-14
2022-06-30	$34,385,522	976,584	+24.5%	Shares	Defined	2024-05-14
2022-03-31	$36,084,489	784,616	+23.3%	Shares	Defined	2022-05-16
2021-12-31	$42,178,600	636,178	-15.7%	Shares	Defined	2022-02-17
2021-09-30	$47,124,473	754,837	-2.5%	Shares	Defined	2022-01-20
2021-06-30	$64,151,212	774,586	-14.8%	Shares	Defined	2021-08-13
2021-06-30	$828,200	10,000	-72.7%	Call	Defined	2021-08-13
2021-03-31	$2,426,946	36,600	+29.8%	Call	Defined	2021-05-17
2021-03-31	$60,292,367	909,250	-17.6%	Shares	Defined	2021-05-17
2020-12-31	$84,666,644	1,103,436	+27.8%	Shares	Defined	2021-02-12
2020-12-31	$2,163,786	28,200	-3.8%	Call	Defined	2021-02-12
2020-09-30	$430,600	10,000	-62.3%	Put	Defined	2020-11-13
2020-09-30	$37,177,443	863,387	+27.8%	Shares	Defined	2020-11-13
2020-09-30	$1,261,658	29,300	+10.6%	Call	Defined	2020-11-13
2020-06-30	$29,177,133	675,553	+31.2%	Shares	Defined	2020-08-12
2020-03-31	$14,811,256	514,816	—	Shares	Defined	2020-05-15
2020-03-31	$762,405	26,500	—	Call	Defined	2020-05-15
2020-03-31	$762,405	26,500	—	Put	Defined	2020-05-15
No filing history on record for this holder in this stock.